Viewing Study NCT01705392


Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2026-01-04 @ 5:59 PM
Study NCT ID: NCT01705392
Status: TERMINATED
Last Update Posted: 2017-02-24
First Post: 2012-10-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab vs Dacarbazine in Metastatic Melanoma
Sponsor: Haukeland University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module